Invesco Ltd. Incyte Corp Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Incyte Corp stock. As of the latest transaction made, Invesco Ltd. holds 3,401,018 shares of INCY stock, worth $283 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,401,018

Previous 3,168,750 7.33%

Holding current value

$283 Million

Previous $192 Million 20.71%

% of portfolio

0.04%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$55.17 - $71.22 $12.8 Million - $16.5 Million	232,268 Added 7.33%	3,401,018 $232 Million
Q1 2025 May 12, 2025	BUY	$60.0 - $75.26 $7.23 Million - $9.07 Million	120,543 Added 3.95%	3,168,750 $192 Million
Q4 2024 Feb 13, 2025	SELL	$65.08 - $83.38 $34.3 Million - $43.9 Million	-526,431 Reduced 14.73%	3,048,207 $211 Million
Q3 2024 Nov 12, 2024	BUY	$57.33 - $68.61 $291,293 - $348,607	5,081 Added 0.14%	3,574,638 $236 Million
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $38.4 Million - $47.9 Million	751,262 Added 26.66%	3,569,557 $216 Million
Q1 2024 May 14, 2024	BUY	$56.55 - $66.59 $4.64 Million - $5.46 Million	81,973 Added 3.0%	2,818,295 $161 Million
Q4 2023 Feb 12, 2024	SELL	$52.16 - $64.19 $61.8 Million - $76.1 Million	-1,185,723 Reduced 30.23%	2,736,322 $172 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $6.98 Million - $7.97 Million	120,838 Added 3.18%	3,922,045 $227 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $16 Million - $19.8 Million	-262,467 Reduced 6.46%	3,801,207 $237 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $93.1 Million - $114 Million	1,326,166 Added 48.44%	4,063,674 $294 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $25.3 Million - $31.7 Million	376,927 Added 15.97%	2,737,508 $220 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $12.5 Million - $15.7 Million	189,163 Added 8.71%	2,360,581 $157 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $25.9 Million - $32.5 Million	391,293 Added 21.98%	2,171,418 $165 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $219,252 - $264,716	3,321 Added 0.19%	1,780,125 $141 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $1.78 Million - $2.09 Million	-28,153 Reduced 1.56%	1,776,804 $130 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $30.5 Million - $37.3 Million	444,265 Added 32.65%	1,804,957 $124 Million
Q2 2021 Aug 17, 2021	BUY	$79.87 - $87.53 $10.1 Million - $11.1 Million	126,333 Added 10.23%	1,360,692 $114 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $15.1 Million - $19.9 Million	198,272 Added 19.14%	1,234,359 $100 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $131 Million - $159 Million	-1,624,417 Reduced 61.06%	1,036,087 $90.1 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $2.68 Million - $3.46 Million	31,552 Added 1.2%	2,660,504 $239 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $50.5 Million - $74.2 Million	-681,361 Reduced 20.58%	2,628,952 $273 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $22.1 Million - $30 Million	-349,059 Reduced 9.54%	3,310,313 $242 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $130 Million - $170 Million	-1,777,916 Reduced 32.7%	3,659,372 $320 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $16.5 Million - $19.6 Million	226,503 Added 4.35%	5,437,288 $404 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $166 Million - $200 Million	2,252,891 Added 76.17%	5,210,785 $443 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $7.65 Million - $10.6 Million	-120,387 Reduced 3.91%	2,957,894 $254 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $180 Million - $215 Million	3,078,281 New	3,078,281 $196 Million

Others Institutions Holding INCY

# of Institutions

730

Shares Held

202M

Call Options Held

516K

Put Options Held

265K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $18.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account